Alice S. Mims

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)”.

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

Leukemia(2023)10.1038/s41375-023-02068-8

N/A

1.8DataRank · unranked

39 citations

Deedra Nicolet, Krzysztof Mrózek, Ayse S. Yilmaz, Jessica Kohlschmidt, Karilyn Larkin +35 more

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

Blood Advances(2022)10.1182/bloodadvances.2022008625

N/A

0.839DataRank · unranked

19 citations

Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock +35 more

A precision medicine classification for treatment of acute myeloid leukemia in older patients

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01110-5

N/A

0.719DataRank · unranked

15 citations

Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld +15 more

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7006

N/A

0.584DataRank · unranked

48 citations

Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Kenneth Byrd +12 more

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Blood Advances(2023)10.1182/bloodadvances.2022009325

N/A

0.524DataRank · unranked

9 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly +15 more

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy

JCI Insight(2023)10.1172/jci.insight.164646

N/A

0.416DataRank · unranked

15 citations

Thomas Drabison, Mahesh R. Nepal, Richard H. Ho, Alix F. Leblanc, Alice A. Gibson +20 more

Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master Trial

Therapeutic Innovation & Regulatory Science(2021)10.1007/s43441-021-00277-w

N/A

0.353DataRank · unranked

5 citations

Hugh Levaux, Ross L. Levine, Amit Shah, James Denmark, Nyla Hereema +18 more

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0091

N/A

0.216DataRank · unranked

3 citations

Ronan Swords, Ying Huang, Shelley Orwick, Daelynn R. Buelow, Nicole Abbott +23 more

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia(2025)10.1038/s41375-025-02644-0

N/A

0.165DataRank · unranked

2 citations

Karilyn Larkin, Deedra Nicolet, Vindi Jurinović, Krzysztof Mrózek, Aarif M.N. Batcha +30 more

Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01553-6

N/A

0.165DataRank · unranked

2 citations

Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy +9 more

White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged <60 years

American Journal of Hematology(2024)10.1002/ajh.27465

N/A

0.124DataRank · unranked

1 citations

Deedra Nicolet, Krzysztof Mrózek, Christopher J. Walker, James S. Blachly, Jessica Kohlschmidt +10 more

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal

Blood Advances(2023)10.1182/bloodadvances.2022009212

N/A

0DataRank · unranked

22 citations

Brian C. Shaffer, Bhavana Bhatnagar, Alice S. Mims, Victoria Klein, Deepika Dilip +9 more

Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1661

N/A

0DataRank · unranked

19 citations

Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F. Madanat, Yuannyu Zhang +23 more

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML

Blood Advances(2022)10.1182/bloodadvances.2022007544

N/A

0DataRank · unranked

35 citations

Deedra Nicolet, Benjamin Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller +25 more

Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.11.005

N/A

0DataRank · unranked

25 citations

Sonata Jodele, Daria Heyenbruch, Jamie Wilhelm, Shawn Thomas, Carolyn Lutzko +12 more

Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax

Blood(2023)10.1182/blood-2023-187861

N/A

0DataRank · unranked

5 citations

Joseph G. Jurcic, Maria R. Baer, William Blum, P. Brent Ferrell, Brian A. Jonas +7 more

Data from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

(2023)10.1158/1078-0432.c.6531362.v1

N/A

0DataRank · unranked

0 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2409876

N/A

0DataRank · unranked

16 citations

Ayush Peddireddi, Subodh Bhatta, Ying Huang, Evandro D. Bezerra, Jonathan E. Brammer +6 more

The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling

Experimental Hematology and Oncology(2024)10.1186/s40164-024-00483-w

N/A

0DataRank · unranked

12 citations

Madeline Halpin, Dominique Corbin, Yerdanos Asemelash, Steven Sher, Britten Gordon +17 more

Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia

JCI Insight(2024)10.1172/jci.insight.173646

N/A

0DataRank · unranked

6 citations

Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C. Vroom, Mariah L. Johnson +28 more

Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia

The Innovation(2024)10.1016/j.xinn.2024.100719

N/A

0DataRank · unranked

5 citations

Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy +15 more

Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-20-1579

N/A

0DataRank · unranked

83 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Qiuhong Zhao, James L. Fisher, Deedra Nicolet +18 more

Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia

Cell stem cell(2025)10.1016/j.stem.2025.04.012

N/A

0DataRank · unranked

19 citations

Soobeom Lee, Zhengxi Sun, Ronan Chaligné, Sanam Loghavi, Georgios Asimomitis +30 more

Barriers and facilitators to representative acute leukemia trial participation at National Cancer Institute-designated comprehensive cancer centers

The Oncologist(2025)10.1093/oncolo/oyaf241

N/A

0DataRank · unranked

3 citations

Eric Blackstone, Anna Revette, Jane E. Roberts, Alice S. Mims, Daniel J. DeAngelo +3 more

Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3724

N/A

0DataRank · unranked

33 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers(2022)10.3390/cancers15010029

N/A

0DataRank · unranked

10 citations

Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick +8 more

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study

Leukemia(2023)10.1038/s41375-023-01846-8

N/A

0DataRank · unranked

74 citations

Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer +14 more